Literature DB >> 7579002

New approaches for treatment in diabetes: aldose reductase inhibitors.

N Hotta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7579002     DOI： 10.1016/0753-3322(96)82629-1

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


× No keyword cloud information.
  12 in total

1.  Antioxidant action of 3-mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1'-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to tert-butyl hydroperoxide.

Authors:  Marta Soltesova Prnova; Jana Ballekova; Magdalena Majekova; Milan Stefek
Journal:  Redox Rep       Date:  2015-06-11       Impact factor: 4.412

2.  Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

Authors:  Mohanraj Rajesh; Partha Mukhopadhyay; Sándor Bátkai; György Haskó; Lucas Liaudet; Viktor R Drel; Irina G Obrosova; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-23       Impact factor: 4.733

3.  Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes.

Authors:  Ghislain Delpierre; François Collard; Juliette Fortpied; Emile Van Schaftingen
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

4.  Lutein prevents the effect of high glucose levels on immune system cells in vivo and in vitro.

Authors:  M Muriach; F Bosch-Morell; E Arnal; G Alexander; R Blomhoff; F J Romero
Journal:  J Physiol Biochem       Date:  2008-06       Impact factor: 4.158

5.  Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

Authors:  V Peponis; M Papathanasiou; A Kapranou; C Magkou; A Tyligada; A Melidonis; T Drosos; N M Sitaras
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

6.  CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors.

Authors:  Hong-Yan Liu; Shu-Shen Liu; Li-Tang Qin; Ling-Yun Mo
Journal:  J Mol Model       Date:  2009-01-09       Impact factor: 1.810

7.  Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.

Authors:  Ivy S Samuels; Chieh-Allen Lee; J Mark Petrash; Neal S Peachey; Timothy S Kern
Journal:  Vis Neurosci       Date:  2012-10-29       Impact factor: 3.241

8.  Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway.

Authors:  Manga Vijjulatha; Yamini Lingala; RaviRaja Tejaswi Merugu
Journal:  J Mol Model       Date:  2014-06-29       Impact factor: 1.810

Review 9.  Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes.

Authors:  Karin Ekberg; Bo-Lennart Johansson
Journal:  Exp Diabetes Res       Date:  2008

Review 10.  Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.

Authors:  Lucia Kovacikova; Marta Soltesova Prnova; Magdalena Majekova; Andrej Bohac; Cimen Karasu; Milan Stefek
Journal:  Molecules       Date:  2021-05-12       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.